Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA approves test that screens patients for InterStim Therapy for Urinary Control

Oct. 1, 2001

New drug for improving ED filed for approval in U.S., Mexico

Sep. 26, 2001

NCX-2111: a new NicOx NO-releasing compound for micturition disorders

Sep. 26, 2001

Phase II trial data support efficacy of duloxetine in stress urinary incontinence

Sep. 21, 2001

Muscarinic receptor binding profile of YM-905 correlated with pharmacological activity

Sep. 20, 2001

Tiagabine as a potential treatment option for overactive bladder

Sep. 20, 2001

Human testing of injectable urethral bulking agent in progress

Sep. 20, 2001

Men with diabetes-related ED respond well to on-demand treatment with IC-351

Sep. 17, 2001

Interneuron initiates U.S. phase III clinical trial with trospium for overactive bladder

Sep. 13, 2001

Topiglan development continues to move forward

Sep. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...